タカラバイオ 普通株式
Id | Date_of_disclosure | Date_of_calculation | Code_of_stock | Name_of_stock_jp | Name_of_stock_en | Name_of_short_seller | Address_of_short_seller | Name_of_discretionary_investment_contractor | Address_of_discretionary_investment_contractor | Name_of_investment_fund | Ratio_of_short_positions_to_shares_outstanding | Number_of_short_positions_in_shares | Number_of_short_positions_in_trading_units | Date_of_calculation_in_previous_reporting | Ratio_of_short_positions_in_previous_reporting | Notes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 679707 | 2024-09-06 | 2024-09-04 | 4974 | タカラバイオ 普通株式 | TAKARA BIO INC. | GOLDMAN SACHS INTERNATIONAL | Plumtree Court 25 Shoe Lane London | nan | nan | nan | 0.0053 | 645595 | 6455 | 2024-08-30 | 0.0046 | 顧客取引に係るヘッジポジション及びETFの場合は当該ETFの設定を伴う空売りを含む |
| 675356 | 2024-09-17 | 2024-09-12 | 4974 | タカラバイオ 普通株式 | TAKARA BIO INC. | GOLDMAN SACHS INTERNATIONAL | Plumtree Court 25 Shoe Lane London | nan | nan | nan | 0.0046 | 554395 | 5543 | 2024-09-04 | 0.0053 | 顧客取引に係るヘッジポジション及びETFの場合は当該ETFの設定を伴う空売りを含む |
| 671859 | 2024-09-25 | 2024-09-20 | 4974 | タカラバイオ 普通株式 | TAKARA BIO INC. | GOLDMAN SACHS INTERNATIONAL | Plumtree Court 25 Shoe Lane London | nan | nan | nan | 0.005 | 610828 | 6108 | 2024-09-12 | 0.0046 | 顧客取引に係るヘッジポジション及びETFの場合は当該ETFの設定を伴う空売りを含む |
| 937440 | 2024-10-07 | 2024-10-03 | 4974 | タカラバイオ 普通株式 | TAKARA BIO INC. | GOLDMAN SACHS INTERNATIONAL | Plumtree Court 25 Shoe Lane London | nan | nan | nan | 0.0049 | 601128 | 6011 | 2024-09-20 | 0.005 | 顧客取引に係るヘッジポジション及びETFの場合は当該ETFの設定を伴う空売りを含む |
| 929226 | 2024-10-24 | 2024-10-22 | 4974 | タカラバイオ 普通株式 | TAKARA BIO INC. | GOLDMAN SACHS INTERNATIONAL | Plumtree Court 25 Shoe Lane London | nan | nan | nan | 0.005 | 606728 | 6067 | 2024-10-03 | 0.0049 | 顧客取引に係るヘッジポジション及びETFの場合は当該ETFの設定を伴う空売りを含む |
| 1203595 | 2024-11-01 | 2024-10-30 | 4974 | タカラバイオ 普通株式 | TAKARA BIO INC. | GOLDMAN SACHS INTERNATIONAL | Plumtree Court 25 Shoe Lane London | nan | nan | nan | 0.0049 | 599329 | 5993 | 2024-10-22 | 0.005 | 顧客取引に係るヘッジポジション及びETFの場合は当該ETFの設定を伴う空売りを含む |
| 1202732 | 2024-11-05 | 2024-10-31 | 4974 | タカラバイオ 普通株式 | TAKARA BIO INC. | GOLDMAN SACHS INTERNATIONAL | Plumtree Court 25 Shoe Lane London | nan | nan | nan | 0.0051 | 617229 | 6172 | 2024-10-30 | 0.0049 | 顧客取引に係るヘッジポジション及びETFの場合は当該ETFの設定を伴う空売りを含む |
| 1202063 | 2024-11-06 | 2024-11-01 | 4974 | タカラバイオ 普通株式 | TAKARA BIO INC. | GOLDMAN SACHS INTERNATIONAL | Plumtree Court 25 Shoe Lane London | nan | nan | nan | 0.0049 | 597371 | 5973 | 2024-10-31 | 0.0051 | 顧客取引に係るヘッジポジション及びETFの場合は当該ETFの設定を伴う空売りを含む |
| 1199945 | 2024-11-11 | 2024-11-07 | 4974 | タカラバイオ 普通株式 | TAKARA BIO INC. | GOLDMAN SACHS INTERNATIONAL | Plumtree Court 25 Shoe Lane London | nan | nan | nan | 0.0051 | 620071 | 6200 | 2024-11-01 | 0.0049 | 顧客取引に係るヘッジポジション及びETFの場合は当該ETFの設定を伴う空売りを含む |
| 1198512 | 2024-11-13 | 2024-11-11 | 4974 | タカラバイオ 普通株式 | TAKARA BIO INC. | GOLDMAN SACHS INTERNATIONAL | Plumtree Court 25 Shoe Lane London | nan | nan | nan | 0.0045000000000000005 | 546371 | 5463 | 2024-11-07 | 0.0051 | 顧客取引に係るヘッジポジション及びETFの場合は当該ETFの設定を伴う空売りを含む |